Lorazepam and Viberzi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Viberzi (eluxadoline). Common drug interactions include asthenia among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Viberzi. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Viberzi?

Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

58 people who take Lorazepam and Viberzi together, and have interactions are studied.

Lorazepam and Viberzi drug interactions.

What are the common drug interactions of Lorazepam and Viberzi, by gender? *:

female:

Asthenia (weakness)
Confusional state
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Erythema (redness of the skin)
Groin abscess (pus in groin)
Infection
Pulmonary embolism (blockage of the main artery of the lung)
Pulse absent
Rectal fissure (painful condition in which a cut or tear occurs in the anus)

male:

Arthralgia (joint pain)
Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
Fluid retention (an abnormal accumulation of fluid in the blood)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Anaemia (lack of blood)
Asthenia (weakness)
Back disorder
Cluster headache (one-sided head pain with tearing)
Cough
Drug intolerance (drug sensitivity)

What are the common drug interactions of Lorazepam and Viberzi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pancreatitis acute (sudden inflammation of pancreas)
Abdominal pain upper
Back injury
Body height decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Constipation
Diarrhoea
Feeling jittery
Lower respiratory tract infection
Nasopharyngitis (inflammation of the nasopharynx)

50-59:

Nausea (feeling of having an urge to vomit)
Abdominal discomfort
Arthralgia (joint pain)
Back pain
Blood pressure increased
Bone pain
Cystitis (inflammation of the wall of the bladder)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Fall

60+:

Arthralgia (joint pain)
Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
Anaemia (lack of blood)
Diarrhoea
Dyspnoea exertional (breathlessness or shortness of breath)
Fatigue (feeling of tiredness)
Oedema (fluid collection in tissue)
Swelling
Abdominal discomfort
Abdominal pain

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 25 people, 43.10%
Irritable Bowel Syndrome: 17 people, 29.31%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 22.41%
Depression: 10 people, 17.24%
High Blood Pressure: 10 people, 17.24%
High Blood Cholesterol: 9 people, 15.52%
Rickets (softening of bones): 8 people, 13.79%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 13.79%
Pain: 8 people, 13.79%
Nausea (feeling of having an urge to vomit): 7 people, 12.07%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Viberzi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously